CDD Vault Integrates NVIDIA Microservices for Enhanced AI-Driven Drug Discovery
Collaborative Drug Discovery, Inc. (CDD) has integrated NVIDIA BioNeMo NIM microservices for AlphaFold2 and DiffDock into its CDD Vault platform. This powerful addition enhances AI capabilities within the web-based system, allowing researchers to visualize small molecules alongside biological proteins and gain deeper insights. The integration strengthens CDD Vault’s existing tools for drug discovery, combining predictive models with chemistry-aware design and ultrafast deep-learning similarity. Researchers in both commercial and humanitarian sectors now benefit from faster, more intuitive decision-making with next-gen AI models.
CDD Vault Integrates NVIDIA Microservices for Enhanced AI-Driven Drug Discovery